微泰医疗器械（杭州）股份有限公司（02235）于2025年12月1日更新翌日披露报表，宣布于同日回购股份。根据公告，公司当日于香港联交所回购111,700股普通H股，占回购前公司已发行股份（不包括库藏股）约0.0672%。最高回购价为每股6.53港元，最低回购价为每股6.30港元，合计支付金额约720,815港元。
回购完成后，公司已发行股份数量变更为166,162,642股，同时库藏股数量增至3,013,200股，总发行股份维持169,175,842股。公告披露，公司于2025年5月28日获得购回授权，可购回最多16,668,364股，截至目前已累计回购461,000股。公司确认本次回购遵守上市规则及相关法律法规。
公告由执行董事及联席公司秘书施永辉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.